The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study

BACKGROUND: The effectiveness of interleukin-6 inhibitors (IL-6i) in ameliorating coronavirus disease 2019 (COVID-19) remains uncertain. METHODS: We analyzed data for patients aged ≥18 years admitted with a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test at 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Pranay, Jafarzadeh, S Reza, Assoumou, Sabrina A, Bielick, Catherine G, Carpenter, Bethanne, Garg, Shivani, Harleen, Sahni, Neogi, Tuhina, Nishio, Midori Jane, Sagar, Manish, Sharp, Veronika, Kissin, Eugene Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717300/
https://www.ncbi.nlm.nih.gov/pubmed/33216906
http://dx.doi.org/10.1093/infdis/jiaa717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717300/
https://www.ncbi.nlm.nih.gov/pubmed/33216906
http://dx.doi.org/10.1093/infdis/jiaa717

Ejemplares similares